Race
Gender

Regeneron Pharmaceuticals

Leadership Diversity:

18%

82%

People of Color

White

The decision makers at Regeneron Pharmaceuticals have approximately 22% less people of color representation as compared to the US population.

Regeneron Pharmaceuticals

Leadership Diversity:

55%

45%

Female

Male

The decision makers at Regeneron Pharmaceuticals have approximately 4% more female representation as compared to the US population.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Description from Wikipedia

Leadership Team

Leonard S. Schleifer

Co-Founder, President and Chief Executive Officer

George D. Yancopoulos

Co-Founder, President and Chief Scientific Officer

Nouhad Husseini

Senior Vice President, Business Development

Robert E. Landry

Executive Vice President, Finance and Chief Financial Officer

Joseph J. LaRosa

Executive Vice President, General Counsel and Secretary

Beth F. Levine

Senior Vice President, Associate General Counsel and Chief Compliance Officer

Marion McCourt

Senior Vice President, Commercial

Hala Mirza

Senior Vice President, Corporate Communications and Citizenship

Sally A. Paull

Senior Vice President, Human Resources

Kerry Reinertsen

Senior Vice President, Strategic Alliances

Deborah Tegan

Senior Vice President, Strategic Sourcing and Procurement